MiraKind conducts patient-centric studies to provide KRAS-variant individuals and their families access to groundbreaking genetic research and a community of support so that together, we can find actionable and meaningful strategies to prevent and treat cancer.Visit the MiraKind community.
Cells are constantly undergoing a process of growth, repair, and death as part of their normal life cycle. The KRAS-variant is an inherited genetic mutation that impairs the cell’s abilities to communicate these signals for self-regulation, resulting in either unchecked cell growth or too few cell deaths, both of which can lead to increased cancer risk.
Despite the dangers of the KRAS-variant mutation, few doctors have heard of it. But one researcher is trying to change that.